1Dustan HP. Does keloid pathogenesis hold the key to understanding black/white differences in hypertension severity? Hypertension, 1995,26(6 Pt 1 ):858-862.
3Ghazizadeh M, Miyata N, Sasaki Y, et al. Silver-stained nucleolar organizer regions in hypertrophic and keloid scars. Am J Dermatopathol,1997, 19(5) :468-472.
4Alaish SM, Yager DR, Diegelmann RF, et al. Hyaluronic acid metabolism in keloid fibroblasts. J Pediatr Surg, 1995, 30(7) :949-952.
5Marneros AG, Norris JE, Olsen BR, et al. Clinical genetics of familial keloids. Arch Dermatol, 2001, 137 ( 11 ): 1429-1434.
6Saed GM, Ladin D, Olson J, et al. Analysis of p53 gene mutations in keloids using polymerase chain reaction-based single-strand conformational polymorphism and DNA sequencing. Arch Dennatol, 1998, 134(8) :963-967.
7Nirodi CS, Devalaraja R, Nanney LB, et al. Chemokine and chemokine receptor expression in keloid and normal fibroblasts. Wound Repair Regen, 2000, 8(5) :371-382.
8Peltonen J, Hsiao LL, Jaakkola S, et al. Activation of collagen gene expression in keloids: co-localization of type Ⅰ and Ⅵ collagen and transforming growth factor-beta 1 mRNA. J Invest Dermatol, 1991,97(2) :240-248.
9Igarashi A, Nashiro K, Kikuchi K, et al. Connective tissue growth factor gene expression in tissue sections from localized scleroderma,keloid, and other fibrotic skin disorders. J Invest Dermatol, 1996,106(4) :729-733.
10Xue H, McCauley RL, Zhang W. Elevated interleukin-6 expression in keloid fibroblasts. J Surg Res, 2000, 89( 1 ) :74-77.
